254 related articles for article (PubMed ID: 9065902)
1. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
Okuda S; Oshio K; Shinmoto H; Tanimoto A; Asada H; Fujii T; Yoshimura Y; Kuribayashi S
Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
[TBL] [Abstract][Full Text] [Related]
3. MR volumetric measurements of the myomatous uterus: improved reliability of stereology over linear measurements.
Joe BN; Suh J; Hildebolt CF; Hovsepian DM; Johnston B; Bae KT
Acad Radiol; 2007 Apr; 14(4):455-62. PubMed ID: 17368215
[TBL] [Abstract][Full Text] [Related]
4. [Triptorelin therapy in uterine leiomyomatosis. Study of 18 cases].
Zarcone R; Monarca M; Vullo G; Bellini P; Carfora E; Tartaglia E
Minerva Ginecol; 1998; 50(1-2):39-42. PubMed ID: 9577154
[TBL] [Abstract][Full Text] [Related]
5. Uterine myoma after cessation of gonadotropin-releasing hormone agonist: ultrasound and histopathologic findings.
Wang PH; Yang AH; Yuan CC; Lee WL; Chao HT
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):625-9. PubMed ID: 9872018
[TBL] [Abstract][Full Text] [Related]
6. Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
Matsuno Y; Yamashita Y; Takahashi M; Katabuchi H; Okamura H; Kitano Y; Shimamura T
Acta Radiol; 1999 Nov; 40(6):656-62. PubMed ID: 10598858
[TBL] [Abstract][Full Text] [Related]
7. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
[No Abstract] [Full Text] [Related]
8. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
[TBL] [Abstract][Full Text] [Related]
9. Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment.
Kawamura N; Ito F; Ichimura T; Shibata S; Umesaki N; Ogita S
Fertil Steril; 1997 Oct; 68(4):632-6. PubMed ID: 9341601
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
11. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of quantitative MR-perfusion imaging to monitor treatment response after uterine artery embolization (UAE) in symptomatic uterus fibroids.
Sadick M; Richers J; Tuschy B; Schad LR; Schoenberg SO; Zöllner FG
Magn Reson Imaging; 2019 Jun; 59():31-38. PubMed ID: 30807812
[TBL] [Abstract][Full Text] [Related]
13. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
14. Role of laparoscopic uterine artery coagulation in management of symptomatic myomas: A prospective study using ultrasound and magnetic resonance imaging.
Simsek M; Sadik S; Taskin O; Guler H; Onoglu A; Akar M; Kursun S; Tinar S
J Minim Invasive Gynecol; 2006; 13(4):315-9. PubMed ID: 16825073
[TBL] [Abstract][Full Text] [Related]
15. Prolapsed leiomyoma with severe haemorrhage after GnRH analogue therapy.
Kriplani A; Agarwal N; Parul D; Bhatla N; Saxena AK
J Obstet Gynaecol; 2002 Jul; 22(4):449-51. PubMed ID: 12521484
[No Abstract] [Full Text] [Related]
16. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment.
Ito F; Kawamura N; Ichimura T; Tsujimura A; Ishiko O; Ogita S
Fertil Steril; 2001 Jan; 75(1):125-30. PubMed ID: 11163826
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy.
Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY
J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041
[TBL] [Abstract][Full Text] [Related]
18. The application of GnRH analogues in the treatment of uterine myomas in perimenopausal women.
Dragojević-Dikić S; Vućić M
Ginekol Pol; 1998 Jan; 69(1):28-33. PubMed ID: 9553319
[TBL] [Abstract][Full Text] [Related]
19. Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review.
Milman D; Zalel Y; Biran H; Open M; Caspi B; Hagay Z; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):237-40. PubMed ID: 9481582
[TBL] [Abstract][Full Text] [Related]
20. A Fast 3-Dimensional Magnetic Resonance Imaging Reconstruction for Surgical Planning of Uterine Myomectomy.
Lee SR; Kim YJ; Kim KG
J Korean Med Sci; 2018 Jan; 33(2):e12. PubMed ID: 29215821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
